TrialThe journal of headache and pain2021

Shift from high-frequency to low-frequency episodic migraine in patients treated with Galcanezumab: results from two global randomized clinical trials.

Jakub Jedynak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.